23 editions on: how Pharma Asia became the meeting place of Pakistan’s pharma industry
From a trade show to the platform where manufacturers, suppliers, regulators and buyers meet every year — what Pharma Asia does for the industry.
In this article
When the 24th Pharma Asia opens at the Karachi Expo Centre on 20 October 2026, it will mark more than two decades of bringing Pakistan’s pharmaceutical industry under one roof. Organised by Ecommerce Gateway Pakistan (Pvt) Ltd, a member of UFI, the Global Association of the Exhibition Industry, it has grown into what the organisers call the biggest pharma sector event of the country.
One place for the whole supply chain
A medicine depends on many industries at once: machinery and tooling, active ingredients and excipients, packaging and printing, laboratories and QC equipment, cleanrooms and utilities. Pharma Asia puts all of them in the same halls as the manufacturers who buy from them. The 2025 edition filled 15,000 square metres and drew more than 25,000 trade visitors and over 514 exhibitors from more than 45 countries.
A recognised industry event
- It is declared an official event of the Pakistan Pharmaceutical Manufacturers Association (PPMA).
- Its strategic supporter is the Special Investment Facilitation Council (SIFC).
- The 2026 edition is supported by the federal and Sindh health ministries, TDAP, the Board of Investment, the Pharma Bureau, the Healthcare Devices Association of Pakistan and PSQCA.
Business, and more than business
For companies, the measure is results: at the last edition, more than 1,050 meetings were confirmed between corporate buyers and exhibitors, and 93% of exhibitors said they met their objective. But the organisers also describe a wider purpose — showing investors the outlook of the regional pharmaceutical industry and helping local companies meet the partners and technology they need to grow.
That mix of trade and learning is why the International Pharma Convention sits alongside the exhibition, and why regulators, academics and students walk the same aisles as buyers.
Why an exhibition still matters
Much of pharmaceutical purchasing now starts online, but the biggest decisions still need people in the same room. A tablet press, a cleanroom or a new API source is a long-term commitment: buyers want to see the machine run, check the build quality, ask the engineer difficult questions and judge whether the supplier will still be there for spare parts and service in ten years. An exhibition lets a plant manager do that with dozens of suppliers in a single day, without the cost of travelling abroad.
For suppliers, the logic runs the other way. Pakistan has hundreds of manufacturers spread across Karachi, Lahore, Islamabad and other cities. Meeting their production heads, QC managers and owners one by one takes months; at Pharma Asia many of them walk the same aisles in three days.
More than a marketplace
Over the years the event has also become a place where the industry talks to itself and to the people who regulate it. The International Pharma Convention, held alongside the exhibition every year since 2014, has hosted DRAP chief executives and directors, heads of Pakistan’s leading manufacturers, international machinery makers and academics. Topics have followed the industry’s own agenda — from GMP and documentation to PIC/S, sterile production, track and trace and exports — so that companies hear about change before it becomes a deadline. Read more in the convention since 2014.
A place for the next generation
The visitor profile includes researchers, students and academics from pharmacy and medical institutions alongside industrialists and executives. For young pharmacists, chemists and engineers, walking an exhibition is often the first chance to see modern equipment and to meet the companies they may one day work for. Universities, too, use the event to connect their research with industry needs. An industry that wants to grow needs that pipeline of skilled people as much as it needs machines.
What 23 editions add up to
Continuity matters in a sector where investment cycles are long. Suppliers that exhibit year after year build relationships that turn into service contracts, distribution agreements and joint ventures; buyers learn which companies stay the course. That steady meeting point — the same place, every year, for the whole supply chain — is the real asset Pharma Asia has built for the industry.
Why it matters now
Pakistan’s industry is working on PIC/S-aligned GMP, track and trace, export growth and local API production. Each of those needs equipment, materials and know-how — much of it on show at Pharma Asia 2026.
